ZEPP Zepp Health Corporation

  1. Stocks
  2. Technology
  3. NYSE: ZEPP

Price (delayed)

$6.74

Market cap

$98.15M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.56

Enterprise value

$213.25M

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 34

Zepp Health Corporation, a biometric and activity data-driven company, develops, manufactures, and sells smart wearable technological devices in the People's Republic of China. It operates through two segments, Xiaomi Wearable ...

Highlights
Zepp Health's net income has increased by 47% YoY and by 39% from the previous quarter
The EPS rose by 45% YoY and by 38% QoQ
The company's quick ratio fell by 29% YoY and by 3% QoQ
ZEPP's debt is up by 26% YoY and by 8% from the previous quarter
Sector: Technology
Industry: Consumer Electronics
Website: https://www.huami.com
Peers: AAPL GRMN GPRO JBL

Key stats

What are the main financial stats of ZEPP

ZEPP stock price

How has the Zepp Health stock price performed over time
Intraday
-0.88%
1 week
-20.61%
1 month
-62.58%
1 year
178.51%
YTD
-74.98%
QTD
-43.6%

Financial performance

How have Zepp Health's revenue and profit performed over time
Revenue
$258.9M
Gross profit
$99.19M
Operating income
-$29.23M
Net income
-$40.07M
Gross margin
38.3%
Net margin
-15.5%
ZEPP's net margin has soared by 63% YoY and by 45% from the previous quarter
ZEPP's operating margin has soared by 56% year-on-year and by 23% since the previous quarter
Zepp Health's net income has increased by 47% YoY and by 39% from the previous quarter
ZEPP's revenue is up by 42% YoY and by 11% QoQ

Price vs fundamentals

How does ZEPP's price correlate with its fundamentals

Growth

What is Zepp Health's growth rate over time

Valuation

What is Zepp Health stock price valuation
P/E
N/A
P/B
0.49
P/S
0.41
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.82
The EPS rose by 45% YoY and by 38% QoQ
ZEPP's price to book (P/B) is 64% less than its last 4 quarters average of 1.4 and 17% less than its 5-year quarterly average of 0.6
Zepp Health's equity has decreased by 15% YoY and by 5% from the previous quarter
The P/S is 68% below the last 4 quarters average of 1.3 and 18% below the 5-year quarterly average of 0.5
ZEPP's revenue is up by 42% YoY and by 11% QoQ

Efficiency

How efficient is Zepp Health business performance
The ROS has soared by 60% YoY and by 38% QoQ
The return on assets has increased by 46% year-on-year and by 40% since the previous quarter
The company's return on equity rose by 37% QoQ and by 28% YoY
The return on invested capital has grown by 37% year-on-year and by 31% since the previous quarter

Dividends

What is ZEPP's dividend history
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
Dividend history

Special dividends are included in TTM DPS and yield

Financial health

How did Zepp Health financials performed over time
ZEPP's total assets is 61% greater than its total liabilities
The company's quick ratio fell by 29% YoY and by 3% QoQ
ZEPP's total liabilities is up by 27% year-on-year but it is down by 2.7% since the previous quarter
ZEPP's debt is 6% more than its equity
Zepp Health's debt to equity has increased by 47% YoY and by 14% QoQ
ZEPP's debt is up by 26% YoY and by 8% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.